Investors Menu
Tilray, Inc. Reports 2020 Second Quarter Results
Revenue Increased 10% to $50.4 Million ( C$69.4 Million ) versus Q2 2019 Cost Savings of $13.0 Million Realized in Q2 2020 – on Pace for Total Annualized Savings of Approximately $55 Million   Net Loss of ($81.7) Million increased $45.4 Million versus Q2 2019 Partially Due to Facilities Closure and
August 10, 2020
Tilray to Report Second Quarter 2020 Financial Results on August 10, 2020
NANAIMO, British Columbia --(BUSINESS WIRE)--Jul. 27, 2020-- Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the second quarter ended June 30, 2020 on Monday, August
July 27, 2020
Tilray, Inc. to Participate in Two Upcoming Virtual Investor Events
NANAIMO, British Columbia --(BUSINESS WIRE)--Jun. 8, 2020-- Tilray, Inc. , (“ Tilray” or the “Company”) (Nasdaq: TLRY) a global leader in cannabis research, cultivation, production and distribution, today announced that management will participate in the following upcoming virtual investor events:
June 8, 2020
Tilray® Receives Complete GMP Certification at EU Campus
Licensing expands company’s international export capacity to serve authorized medical cannabis markets Provides authorization to complete medical cannabis extraction on-site and the production of bulk extracts to manufacture medical cannabis oil as a finished product Certification signals another
May 27, 2020
Tilray® Announces Optimization Plan for Adult-Use Facilities in Canada
Company to close High Park Gardens , licensed cannabis greenhouse located in Leamington, Ontario Facility closure expected to yield $7.5 million in annualized net savings as part of global cost-efficiency and restructuring measures to achieve profitability and grow revenues High Park Farms and High
May 26, 2020
Tilray, Inc. Reports First Quarter 2020 Financial Results
Quarterly Revenue Increased 126% to $52.1 Million ( C$70.7 Million ) Compared to the First Quarter of 2019 and 11% Sequentially from the Fourth Quarter of 2019 International Medical Cannabis Sales Exceeded Canada Medical Sales by 43% in the Quarter Implemented Cost Reductions Designed to Achieve
May 11, 2020
Tilray to Report First Quarter 2020 Financial Results on May 11, 2020
NANAIMO, British Columbia --(BUSINESS WIRE)--May 4, 2020-- Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the first quarter ended March 31, 2020 on Monday, May 11,
May 4, 2020
Tilray, Inc. Releases 11 Million Shares From Lock-Up Agreement
NANAIMO, British Columbia --(BUSINESS WIRE)--Mar. 31, 2020-- Tilray, Inc. (NASDAQ: TLRY) (“Tilray”), a global pioneer in cannabis production, research, cultivation and distribution, today announced that the Board of Directors of Tilray unanimously approved the pro rata release of 11 million shares
March 31, 2020
Tilray, Inc. Announces Pricing of its $90.4 Million Registered Offering
NANAIMO, British Columbia --(BUSINESS WIRE)-- Tilray, Inc. (“ Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today that it has priced an underwritten registered offering of 7,250,000 shares of its Class 2 common
March 13, 2020